News

Elon Musk’s Neuralink is planning to raise about $500 million at a pre-money valuation of $8.5 billion, according to people ...
EXCLUSIVE: Amazon MGM Studios has landed film rights to James Patterson and Duane Swierczynski’s forthcoming book, Billion-Dollar Ransom. The feature take is currently in the works with Traffic ...
The next-generation SSN(X) submarine will allow the Navy to control contested sea lanes around the world. The U.S. Navy’s next-generation SSN(X) attack submarine is not immune to the ...
MONTEGO BAY, Jamaica — More than half-a-billion dollars will be spent at Harmony Beach Park in Montego Bay to repair groyne damage from unusually heavy surges in February 2024 plus add finishing ...
Artificial intelligence (AI) is powerful and may accelerate your startup planning – but on its own, it won’t start or build a billion-dollar company (or will it?). The most successful ...
“Do you really think that we would talk about $3 billion dollar investments and be one of the largest companies in our space if we really weren’t doing what we’re doing?” he continued ...
Eli Lilly's oral GLP-1 medicine aced a phase 3 study. It should become a new growth driver for the company. There are other reasons to invest in the pharmaceutical leader. Zepbound's prospects ...
The White House has not yet clarified the extent of tariffs on pharmaceuticals, meanwhile, Swiss giant Roche has announced a massive $50 billion (43 billion euros) investment in the United States ...
Jamie Foxx has long been an iconic figure in Hollywood. He is among the very few who have effortlessly blended his talent as an actor, comedian, and musician to build a career that is critically ...
James Patterson’s Next Novel ‘Billion-Dollar Ransom’ Getting Big Screen Adaptation From Amazon MGM Studios, 6th & Idaho, Stephen Gaghan Anthony D'Alessandro Tue, April 22, 2025 at 5:16 PM UTC ...
This is partly thanks to Zepbound, a weight loss medicine that's already generating more than $1 billion in quarterly sales, although it was approved only in late 2023. Zepbound's prospects still ...